These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24306962)

  • 1. Native American ancestry, lung function, and COPD in Costa Ricans.
    Chen W; Brehm JM; Boutaoui N; Soto-Quiros M; Avila L; Celli BR; Bruse S; Tesfaigzi Y; Celedón JC
    Chest; 2014 Apr; 145(4):704-710. PubMed ID: 24306962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function.
    Kim W; Moll M; Qiao D; Hobbs BD; Shrine N; Sakornsakolpat P; Tobin MD; Dudbridge F; Wain LV; Ladd-Acosta C; Chatterjee N; Silverman EK; Cho MH; Beaty TH
    JAMA Netw Open; 2021 Dec; 4(12):e2139525. PubMed ID: 34913977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study.
    Parker MM; Foreman MG; Abel HJ; Mathias RA; Hetmanski JB; Crapo JD; Silverman EK; Beaty TH;
    Genet Epidemiol; 2014 Nov; 38(7):652-9. PubMed ID: 25112515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study.
    Powell R; Davidson D; Divers J; Manichaikul A; Carr JJ; Detrano R; Hoffman EA; Jiang R; Kronmal RA; Liu K; Punjabi NM; Shahar E; Watson KE; Rotter JI; Taylor KD; Rich SS; Barr RG
    Thorax; 2013 Jul; 68(7):634-642. PubMed ID: 23585509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.
    Moll M; Sakornsakolpat P; Shrine N; Hobbs BD; DeMeo DL; John C; Guyatt AL; McGeachie MJ; Gharib SA; Obeidat M; Lahousse L; Wijnant SRA; Brusselle G; Meyers DA; Bleecker ER; Li X; Tal-Singer R; Manichaikul A; Rich SS; Won S; Kim WJ; Do AR; Washko GR; Barr RG; Psaty BM; Bartz TM; Hansel NN; Barnes K; Hokanson JE; Crapo JD; Lynch D; Bakke P; Gulsvik A; Hall IP; Wain L; ; ; Weiss ST; Silverman EK; Dudbridge F; Tobin MD; Cho MH
    Lancet Respir Med; 2020 Jul; 8(7):696-708. PubMed ID: 32649918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum Folate Concentration Is Associated with Better Lung Function in Male Chronic Obstructive Pulmonary Disease Patients Who Are Current Smokers: Analysis of Nationwide Population-Based Survey.
    Kim T; Oak CH; Jung MH; Jang TW; Kim J
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 11. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
    Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG
    Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the causal role of physical activity and leisure sedentary behaviours with chronic obstructive pulmonary disease: a Mendelian randomisation study.
    Xiao L; Li W; Li F; Chen X; Xu Y; Hu Y; Fu Y; Feng L
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38688688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
    Bhatt SP; Kim YI; Harrington KF; Hokanson JE; Lutz SM; Cho MH; DeMeo DL; Wells JM; Make BJ; Rennard SI; Washko GR; Foreman MG; Tashkin DP; Wise RA; Dransfield MT; Bailey WC;
    Thorax; 2018 May; 73(5):414-421. PubMed ID: 29326298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset COPD and Decline in Lung Function Among Wood Dust-Exposed Workers: Re-analysis of a 6-year Follow-up Study.
    Bolund ACS; Miller MR; Jacobsen GH; Sigsgaard T; Schlünssen V
    Ann Work Expo Health; 2018 Nov; 62(9):1064-1076. PubMed ID: 30165410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.